#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema Alveolar proteinosis Acute lymphocytic leukaemia recurrent Follicular lymphoma stage III Acute myeloid leukaemia (in remission) Myocarditis B-cell lymphoma recurrent Hyperchylomicronaemia Glycogen storage disease type II Prolymphocytic leukaemia Juvenile psoriatic arthritis IPEX syndrome Giant cell tumour of tendon sheath Hepatitis D Anti-HLA antibody test positive More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Diagnostics Myxofibrosarcoma Retinoblastoma – Treatment Primary immunodeficiency syndrome – Basic Information Thrombotic thrombocytopenic purpura – Trials in Disease Vascular malformation – Basic Information Mast cell activation syndrome – Trials in Disease Paroxysmal nocturnal haemoglobinuria Leukoencephalopathy Thrombotic thrombocytopenic purpura More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amikacin Sulfate Timolol Isotretinoin AMO959 Pivekimab Sunirine Magnesium Ivospemin Mercaptopurine Monohydrate Enalapril Polatuzumab Vedotin Vinflunine Cefepime Hydrochloride DISODIUM PHOSPHATE Lisocabtagene Maraleucel ALPROSTADIL Saline Daratumumab Idecabtagene Vicleucel Vitamin A Bp Vesleteplirsen More therapies…

    Learn about Your Condition

    Laryngeal cancer stage I Left ventricular dysfunction Gestational diabetes Lung adenocarcinoma stage IV Hyponatraemia Haemoglobinuria Primary hypercholesterolaemia Leukaemia Pleural mesothelioma malignant Corneal graft failure Oesophagogastroscopy Metastases to liver Dementia with Lewy bodies Limb reduction defect Skin ulcer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Obeticholic Acid for Children with Biliary Atresia After Kasai Procedure

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Congenital absence of bile ducts
    Investigated Drugs:
    • Obeticholic Acid
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on ALXN1850 and Asfotase Alfa for Children Aged 2-12 with Hypophosphatasia Previously Treated with Asfotase Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    • Asfotase Alfa
    France Germany Italy

  • Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Bt8009
    • Avelumab
    • Carboplatin
    Spain

  • Study on Teverelix for Patients with Advanced Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Teverelix
    Lithuania

  • Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nervous system disorder
    Investigated Drugs:
    • Ocrelizumab
    • Dexamethasone Acetate
    • Lidocaine Hydrochloride Monohydrate
    Czechia France Germany

  • Study on the Effectiveness of Trastuzumab, Pertuzumab, and Docetaxel for Patients with Early HER2-Positive Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Pertuzumab
    Finland Sweden
Previous Page
1 … 873 874 875 876 877 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!